iomeprol
Sign in to saveAlso known as N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(N-methylglycolamido)isophthalamide
Iomeprol, sold under the brand name Imeron among others, is a medication used as a radiocontrast agent in X-ray imaging.
Research
948 papers- Iomeprol: a review of its use as a contrast medium.Drugs · 2000
- Clinical pharmacology of iomeprol.European journal of radiology · 1994
- Iomeprol-induced acute generalised exanthematous pustulosis (AGEP).BMJ case reports · 2025
- Clinical utility and safety profile of iomeprol.European journal of radiology · 1994
- Stability testing of iomeprol and iopamidol formulations subjected to X-ray radiation.Radiography (London, England : 1995) · 2024
via PubMed
Wikidata facts
- Mass
- 776.854
Show 3 more facts
- chemical formula
- C₁₇H₂₂I₃N₃O₈
- canonical SMILES
- CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
- World Health Organisation international non-proprietary name
- iomeprol
Sources (2)
via Wikidata · CC0
~1 min read
Article
5 sectionsContents
- Side effects
- Society and culture
- Legal status
- Brand names
- References
Iomeprol, sold under the brand name Imeron among others, is a medication used as a radiocontrast agent in X-ray imaging.
Iomeprol was approved for medical use in the United States in November 2024.
Available in 7 languages
via Wikidata sitelinks · CC0
Connections
radiocontrast agent
Entity
MRI contrast agent
Entity
microparticle
Entity
medication
Entity
kidney
Entity
International Standard Book Number
Entity
metabolism
Entity
gadolinium
Entity
X-ray
Entity
chemical formula
Entity
ionic bond
Entity
ester
Entity
molar mass
Entity
fatty acid
Entity
OCLC, Inc.
Entity
solubility
Entity
excretion
Entity
phospholipids
Entity
galactose
Entity
CAS Registry Number
Entity